US Broker Ratings

Johnson & Johnson (JNJ) Stock Analysis: A 7% Potential Upside with Strong Buy Ratings

Johnson & Johnson (NYSE: JNJ), a titan in the healthcare sector, stands as a stalwart presence in the Drug Manufacturers – General industry. With a commanding market capitalization of $630.04..

United Therapeutics Corporation (UTHR) Stock Analysis: 18.7% Potential Upside Beckons Investors

United Therapeutics Corporation (NASDAQ: UTHR), a prominent player in the healthcare sector, is gaining attention for its contributions to the drug manufacturing industry, specifically in the realm of specialty and..

Eli Lilly & Co. (LLY) Stock Analysis: Evaluating a Healthcare Giant with 12.79% Upside Potential

Eli Lilly and Company (NYSE: LLY), a titan in the healthcare sector, has been making waves in the financial markets with a formidable market cap of $1.05 trillion. As a..

The Ensign Group, Inc. (ENSG) Stock Analysis: Exploring a 28% Upside Potential

Investors keeping an eye on The Ensign Group, Inc. (NASDAQ: ENSG) are presented with an intriguing opportunity as the company showcases a notable potential upside of 28.06%. Operating in the..

Encompass Health Corporation (EHC) Stock Analysis: Robust Growth Prospects and 20% Upside Potential

Encompass Health Corporation (NYSE: EHC), with its robust operational focus on rehabilitation hospitals throughout the United States and Puerto Rico, stands as a beacon of growth within the healthcare sector...

Medpace Holdings, Inc. (MEDP) Stock Analysis: Evaluating Growth Potential Amidst Robust Revenue Performance

Medpace Holdings, Inc. (NASDAQ: MEDP) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. Based in Cincinnati, Ohio, and serving global markets including..

Labcorp Holdings Inc. (LH) Stock Analysis: Understanding the 10.56% Potential Upside

Investors seeking opportunities in the healthcare sector might find Labcorp Holdings Inc. (NYSE: LH) an intriguing option. As a leading company in the Diagnostics & Research industry, Labcorp provides a..

BioNTech SE (BNTX) Stock Analysis: Exploring a 19.66% Potential Upside Amidst Biotech Volatility

BioNTech SE (NASDAQ: BNTX), a prominent player in the biotechnology sector, has been a focal point for investors seeking opportunities in the healthcare industry. Headquartered in Mainz, Germany, BioNTech specializes..

Natera, Inc. (NTRA) Stock Analysis: Exploring Growth Potential Amidst Strong Revenue Growth

Natera, Inc. (NASDAQ: NTRA) stands as a significant player in the healthcare sector, specifically within the diagnostics and research industry. The company, headquartered in Austin, Texas, has carved a niche..

Agilent Technologies, Inc. (A) Stock Analysis: Navigating Growth with a 4.67% Potential Upside

Agilent Technologies, Inc. (NYSE: A), a key player in the healthcare sector’s Diagnostics & Research industry, presents an intriguing opportunity for investors eyeing the life sciences and diagnostics markets. With..

BeOne Medicines Ltd. (ONC) Stock Analysis: Unveiling a 22.87% Upside Potential in Biotech Innovation

BeOne Medicines Ltd. (ONC), a Swiss-based biotechnology powerhouse, is capturing the attention of investors with its remarkable growth potential and innovative strides in oncology. With a market capitalization of $40.33..

The Cigna Group (CI) Stock Analysis: Exploring a 21% Potential Upside with Strong Buy Ratings

The Cigna Group (CI), a prominent player in the healthcare sector, has been capturing investor attention with its recent performance and promising potential upside. As the U.S. healthcare landscape continues..

Becton, Dickinson and Company (BDX) Stock Analysis: Exploring Growth Potential in the Medical Instruments Industry

Becton, Dickinson and Company (NYSE: BDX), a giant in the healthcare sector, continues to capture investor attention with its significant role in developing and manufacturing medical supplies and devices. With..

Elevance Health, Inc. (ELV) Stock Analysis: Exploring a 9.4% Potential Upside in the Healthcare Sector

Elevance Health, Inc. (NYSE: ELV), a prominent player in the healthcare plans industry, stands out with its robust market presence and significant growth potential. With a commanding market capitalization of..

The Cooper Companies, Inc. (COO) Stock Analysis: Exploring a 21% Potential Upside in the Healthcare Sector

Investors seeking opportunities in the healthcare sector may find The Cooper Companies, Inc. (NYSE: COO) an intriguing prospect, particularly given the stock’s potential upside of 21.02%. With a substantial market..

Neurocrine Biosciences (NBIX) Stock Analysis: Promising Upside with a 45.53% Potential Boost

Investors seeking opportunities in the healthcare sector may find Neurocrine Biosciences, Inc. (NBIX) an attractive candidate. With a robust market cap of $14.48 billion, this San Diego-based biotech company is..

Royalty Pharma plc (RPRX) Stock Analysis: Exploring a 14.83% Upside Potential with Robust Revenue Growth

Royalty Pharma plc (NASDAQ: RPRX) stands as a unique player in the biotechnology sector, operating primarily as a buyer of biopharmaceutical royalties and a funder of innovation. With a robust..

Illumina, Inc. (ILMN) Stock Analysis: Navigating High Valuation and Strategic Collaborations

For investors considering a stake in Illumina, Inc. (NASDAQ: ILMN), a leading player in the healthcare sector’s diagnostics and research industry, the current landscape offers a mix of high potential..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Evaluating a 7.07% Potential Upside Amid Mixed Financials

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a prominent player in the healthcare sector, is a notable name in the specialty and generic drug manufacturing industry. Headquartered in Hyderabad, India, this..

argenx SE (ARGX) Stock Analysis: A Strong Buy with 39.93% Upside Potential

argenx SE (NASDAQ: ARGX), a prominent player in the biotechnology sector, has captured the attention of investors with its significant market capital of $51.88 billion and a promising pipeline of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds